Sienna Biopharmaceuticals, Inc.. (SNNA) NASDAQ
$0.14 - (-)
Market Cap: $4.20M
As of 12/16/19 12:00 AM EST. Market closed.
Sienna Biopharmaceuticals, Inc.. (SNNA)
NASDAQ
$0.14
- (-)
Market Cap: $4.20M
As of 12/16/19 12:00 AM EST. Market closed.
Add to Portfolio
Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by ... read more
COMPANY PROFILE
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Frederick C. Beddingfield
Full Time Employees
58
CEO Compensation (Base)
$508,000
CEO Compensation (Total)
$2.62M
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Frederick C. Beddingfield
Full Time Employees
58
CEO Compensation (Base)
$508,000
CEO Compensation (Total)
$2.62M
Address
30699 Russell Ranch Road, CA, Westlake Village, 91362.
PRICE CHART FOR SIENNA BIOPHARMACEUTICALS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.14
Days Range
- - -
52 week range
$0.11 - $0.17
Volume
0
Avg. Volume (30 days)
13,315,740
Market Cap
$4.20M
Dividend Yield
-
P/E
-
Shares Outstanding
30,907,500
Open
-
Previous Close
$0.14
Days Range
- - -
52 week range
$0.11 - $0.17
Volume
0
Avg. Volume (30 days)
13,315,740
Market Cap
$4.20M
Dividend Yield
-
P/E
-
Shares Outstanding
30,907,500
FINANCIAL STATEMENTS FOR SIENNA BIOPHARMACEUTICALS, INC.
LOADING...
INSIDER TRANSACTIONS FOR SIENNA BIOPHARMACEUTICALS, INC.
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Azoy Alexander | Chief Financial Officer | Oct 02, 2019 | Option Exercise | $0.23 | 2,396 | 551 | 103,552 | Oct 04, 2019, 02:10 PM |
Stroehmann Diane | See Remarks | Jul 02, 2019 | Option Exercise | $0.76 | 4,095 | 3,112 | 168,545 | Jul 03, 2019, 01:47 PM |
Andrews Timothy K. | General Counsel & Secretary | Jul 02, 2019 | Option Exercise | $0.76 | 4,095 | 3,112 | 95,558 | Jul 03, 2019, 01:42 PM |
Lizzul Paul F. | Chief Medical Officer | Jul 02, 2019 | Option Exercise | $0.76 | 4,095 | 3,112 | 141,488 | Jul 03, 2019, 01:39 PM |
Beddingfield III Frederick | President & CEO | Jul 02, 2019 | Option Exercise | $0.76 | 17,063 | 12,968 | 817,599 | Jul 03, 2019, 01:35 PM |
Azoy Alexander | Chief Financial Officer | Jul 02, 2019 | Option Exercise | $0.76 | 1,552 | 1,180 | 35,948 | Jul 03, 2019, 12:00 AM |
ARCH Venture Partners X, LLC | 10% Owner | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:08 PM |
ARCH Venture Partners VIII, LLC | 10% Owner | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:06 PM |
Burow Kristina | Director | Feb 22, 2019 | Buy | $2.50 | 2,165,800 | 5,414,500 | 2,900,575 | Feb 26, 2019, 09:03 PM |
MORE ROBERT J | Director | Feb 22, 2019 | Buy | $2.50 | 100,000 | 250,000 | 255,942 | Feb 26, 2019, 05:16 PM |
Leonard Keith R | Director | Feb 22, 2019 | Buy | $2.50 | 100,000 | 250,000 | 100,000 | Feb 26, 2019, 05:14 PM |
Beddingfield III Frederick | President & CEO | Feb 22, 2019 | Buy | $2.50 | 40,000 | 100,000 | 831,662 | Feb 26, 2019, 05:12 PM |
Harris Todd | Head of Corporate Development | Apr 30, 2018 | Sale | $20.00 | 100 | 2,000 | 570,991 | May 02, 2018, 07:54 PM |
Harris Todd | Head of Corporate Development | Apr 25, 2018 | Sale | $20.00 | 300 | 6,000 | 571,091 | Apr 25, 2018, 07:21 PM |
Harris Todd | Head of Corporate Development | Apr 24, 2018 | Sale | $20.00 | 150 | 3,000 | 571,391 | Apr 25, 2018, 07:21 PM |
Harris Todd | Head of Corporate Development | Apr 23, 2018 | Sale | $20.00 | 525 | 10,500 | 571,541 | Apr 25, 2018, 07:21 PM |
Harris Todd | Head of Corporate Development | Apr 18, 2018 | Sale | $20.09 | 15,810 | 317,599 | 572,066 | Apr 19, 2018, 06:00 PM |
Harris Todd | Head of Corporate Development | Apr 17, 2018 | Sale | $20.00 | 2,201 | 44,020 | 587,876 | Apr 19, 2018, 06:00 PM |
Harris Todd | Head of Corporate Development | Apr 10, 2018 | Sale | $20.02 | 3,779 | 75,641 | 590,077 | Apr 12, 2018, 06:45 PM |
Harris Todd | Head of Corporate Development | Apr 09, 2018 | Sale | $20.00 | 2,824 | 56,480 | 593,856 | Apr 09, 2018, 07:18 PM |
Harris Todd | Head of Corporate Development | Apr 05, 2018 | Sale | $20.00 | 5,386 | 107,725 | 596,680 | Apr 09, 2018, 07:18 PM |
MORE ROBERT J | Director | Mar 29, 2018 | Sale | $18.78 | 14,429 | 270,977 | 178,820 | Mar 29, 2018, 08:50 PM |
MORE ROBERT J | Director | Mar 28, 2018 | Sale | $18.84 | 10,000 | 188,400 | 193,249 | Mar 29, 2018, 08:50 PM |
Harris Todd | Head of Corporate Development | Mar 19, 2018 | Sale | $20.00 | 5,876 | 117,520 | 602,066 | Mar 20, 2018, 07:00 PM |
Harris Todd | Head of Corporate Development | Mar 12, 2018 | Sale | $20.11 | 3,452 | 69,429 | 607,942 | Mar 14, 2018, 07:13 PM |
Harris Todd | Head of Corporate Development | Mar 08, 2018 | Sale | $20.03 | 14,530 | 291,097 | 613,832 | Mar 09, 2018, 07:00 PM |
Harris Todd | Head of Corporate Development | Mar 07, 2018 | Sale | $20.00 | 3,704 | 74,080 | 628,362 | Mar 09, 2018, 07:00 PM |
Harris Todd | Head of Corporate Development | Mar 09, 2018 | Sale | $20.01 | 2,438 | 48,784 | 611,394 | Mar 09, 2018, 07:00 PM |
FENTON DENNIS M | Director | Sep 18, 2017 | Buy | $22.96 | 1,250 | 28,698 | 1,250 | Sep 19, 2017, 11:56 AM |
Stroehmann Diane | See Remarks | Aug 01, 2017 | Buy | $15.00 | 7,000 | 105,000 | 124,724 | Aug 01, 2017, 04:27 PM |
PETERSON RICHARD D | Chief Financial Officer | Aug 01, 2017 | Buy | $15.00 | 7,000 | 105,000 | 7,000 | Aug 01, 2017, 04:26 PM |
MAST ERLE T | Director | Aug 01, 2017 | Buy | $15.00 | 6,700 | 100,500 | 6,700 | Aug 01, 2017, 04:24 PM |
Lizzul Paul F. | Chief Medical Officer | Aug 01, 2017 | Buy | $15.00 | 10,000 | 150,000 | 94,634 | Aug 01, 2017, 04:23 PM |
Leonard Keith R | Director | Aug 01, 2017 | Buy | $15.00 | 16,700 | 250,500 | 16,700 | Aug 01, 2017, 04:22 PM |
Andrews Timothy K. | General Counsel & Secretary | Aug 01, 2017 | Buy | $15.00 | 15,000 | 225,000 | 15,000 | Aug 01, 2017, 04:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Azoy Alexander | Chief Financial Officer | 10/02/2019 | 551 |
Stroehmann Diane | See Remarks | 07/02/2019 | 3,112 |
Andrews Timothy K. | General Counsel & Secretary | 07/02/2019 | 3,112 |
Lizzul Paul F. | Chief Medical Officer | 07/02/2019 | 3,112 |
Beddingfield III Frederick | President & CEO | 07/02/2019 | 12,968 |
Azoy Alexander | Chief Financial Officer | 07/02/2019 | 1,180 |
ARCH Venture Partners X, LLC | 10% Owner | 02/22/2019 | 5,414,500 |
ARCH Venture Partners VIII, LLC | 10% Owner | 02/22/2019 | 5,414,500 |
Burow Kristina | Director | 02/22/2019 | 5,414,500 |
MORE ROBERT J | Director | 02/22/2019 | 250,000 |
Leonard Keith R | Director | 02/22/2019 | 250,000 |
Beddingfield III Frederick | President & CEO | 02/22/2019 | 100,000 |
Harris Todd | Head of Corporate Development | 04/30/2018 | 2,000 |
Harris Todd | Head of Corporate Development | 04/25/2018 | 6,000 |
Harris Todd | Head of Corporate Development | 04/24/2018 | 3,000 |
Harris Todd | Head of Corporate Development | 04/23/2018 | 10,500 |
Harris Todd | Head of Corporate Development | 04/18/2018 | 317,599 |
Harris Todd | Head of Corporate Development | 04/17/2018 | 44,020 |
Harris Todd | Head of Corporate Development | 04/10/2018 | 75,641 |
Harris Todd | Head of Corporate Development | 04/09/2018 | 56,480 |
Harris Todd | Head of Corporate Development | 04/05/2018 | 107,725 |
MORE ROBERT J | Director | 03/29/2018 | 270,977 |
MORE ROBERT J | Director | 03/28/2018 | 188,400 |
Harris Todd | Head of Corporate Development | 03/19/2018 | 117,520 |
Harris Todd | Head of Corporate Development | 03/12/2018 | 69,429 |
Harris Todd | Head of Corporate Development | 03/08/2018 | 291,097 |
Harris Todd | Head of Corporate Development | 03/07/2018 | 74,080 |
Harris Todd | Head of Corporate Development | 03/09/2018 | 48,784 |
FENTON DENNIS M | Director | 09/18/2017 | 28,698 |
Stroehmann Diane | See Remarks | 08/01/2017 | 105,000 |
PETERSON RICHARD D | Chief Financial Officer | 08/01/2017 | 105,000 |
MAST ERLE T | Director | 08/01/2017 | 100,500 |
Lizzul Paul F. | Chief Medical Officer | 08/01/2017 | 150,000 |
Leonard Keith R | Director | 08/01/2017 | 250,500 |
Andrews Timothy K. | General Counsel & Secretary | 08/01/2017 | 225,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR SIENNA BIOPHARMACEUTICALS, INC.
LOADING...